SCHEMBL8307237

SCHEMBL8307237

CCCCS(=O)(=O)Nc1ccc(Oc2cccc3ccccc23)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.56
MRGPRX1 Q96LB2 3/20 0.55
BCL2L1 Q07817 1/20 0.48
MCL1 Q07820 1/20 0.48
PGR P06401 2/20 0.47
BRD4 O60885 2/20 0.46
LMNA P02545 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MITF O75030 1/20 0.46
POLB P06746 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
HPGD P15428 2/20 0.44
MAPT P10636 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CARM1 Q86X55 1/20 0.43
PRMT6 Q96LA8 1/20 0.43
KDR P35968 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7228204 0.83 PGR (0.51) ARBCL2L1MCL1PGRLMNA
SCHEMBL7219583 0.83 AR (0.51) ARMRGPRX1BCL2L1MCL1BRD4
SCHEMBL7227793 0.82 MRGPRX1 (0.45) MRGPRX1BCL2L1MCL1LMNAMEN1
SCHEMBL7222716 0.82 MRGPRX1 (0.54) ARMRGPRX1BRD4LMNAMEN1
SCHEMBL7222256 0.82 BRD4 (0.47) ARMRGPRX1BCL2L1MCL1BRD4
SCHEMBL7221201 0.82 AR (0.47) ARMRGPRX1BCL2L1MCL1BRD4
SCHEMBL9447116 0.81 AR (0.52) ARMRGPRX1LMNAHPGDMAPT
SCHEMBL7220116 0.81 BCL2L1 (0.48) ARBCL2L1MCL1BRD4LMNA
SCHEMBL7220099 0.81 BCL2L1 (0.48) BCL2L1MCL1PGRLMNAMEN1
SCHEMBL7460395 0.81 BCL2L1 (0.51) BCL2L1MCL1PGRLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0966436-A1 ARYL SULFONAMIDES AND ANALOGUES THEREOF AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES Bayer Aktiengesellschaft (DE) 1999-12-29 EP disclosed
WO-1998037061-A1 ARYL SULFONAMIDES AND ANALOGUES THEREOF AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES BAYER AKTIENGESELLSCHAFT (DE) 1998-08-27 WO disclosed